Myo-inositol in assisted reproductive technology from bench to bedside

Andrea Etrusco,Antonio Simone Laganà,Vito Chiantera,Giovanni Buzzaccarini,Vittorio Unfer
DOI: https://doi.org/10.1016/j.tem.2023.09.005
Abstract:Inositols are insulin-sensitizing compounds of promising efficacy in the management of polycystic ovary syndrome (PCOS). On the one hand, myo-inositol (myo-ins) plays a regulatory role in male and female reproductive function, influencing the development of oocytes, spermatozoa, and embryos. On the other hand, high concentrations of D-chiro-inositol (D-chiro-ins) in the ovary may adversely affect oocyte quality. This review analyses the available literature, which encourages the clinical use of myo-ins in assisted reproductive technologies (ARTs) due to its beneficial effects on female and male reproduction.
What problem does this paper attempt to address?